Article Text

PDF
Letter
Authors' response
  1. Charles H Knowles1,
  2. Roberto De Giorgio2 on behalf of the IWG
  1. 1Neurogastroenterology Group, Centre for digestive diseases, Institute of Cellular and Molecular Science, Barts and the London, Queen Mary's School of Medicine and Dentistry, London, UK
  2. 2Department of Clinical Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy
  1. Correspondence to Charles H Knowles, Neurogastroenterology Group, Centre for digestive diseases, Institute of Cellular and Molecular Science, Barts and the London, Queen Mary's School of Medicine and Dentistry, London E1 2AN, UK; c.h.knowles{at}qmul.ac.uk

Statistics from Altmetric.com

We thank Professors Bassotti and Villanacci1 for first highlighting the importance of the London Classification.2 In response to their comments on the rigidity of the current classification, we would first note that the classification does not in any way prevent the diagnosis of more than one histological finding in an individual patient. Thus, their concept of neuromyopathies, neurogliopathies and neuromesenchymopathies are not invalidated as diagnoses. Indeed, we acknowledge that more …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles